SOUTH SAN FRANCISCO, Calif., November 4, 2025 -- Standard BioTools Inc. (NASDAQ: LAB) (the "Company" or "Standard BioTools") today announced financial results for the quarter ended September 30, 2025. Recent Highlights: "The third quarter marked another period of solid execution as we sharpen our focus and position Standard BioTools for the next stage," said Michael Egholm, PhD, President and Chief Executive Officer of Standard BioTools. "Our commercial team delivered consistent overall performance amid a s ...